SHIVA GUPTA to Retrospective Studies
This is a "connection" page, showing publications SHIVA GUPTA has written about Retrospective Studies.
Connection Strength
0.108
-
Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). Abdom Radiol (NY). 2020 06; 45(6):1872-1882.
Score: 0.036
-
Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness. Abdom Radiol (NY). 2016 07; 41(7):1317-24.
Score: 0.027
-
Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms. J Comput Assist Tomogr. 2022 May-Jun 01; 46(3):333-343.
Score: 0.010
-
Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Neuro Oncol. 2019 11 04; 21(11):1458-1469.
Score: 0.009
-
Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features. Clin Gastroenterol Hepatol. 2018 09; 16(9):1481-1487.
Score: 0.008
-
Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy. AJR Am J Roentgenol. 2017 Dec; 209(6):1278-1284.
Score: 0.007
-
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study. Arch Neurol. 2009 Jan; 66(1):39-43.
Score: 0.004
-
In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2006 Nov-Dec; 27(10):2161-7.
Score: 0.003
-
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations. Arch Neurol. 2005 Nov; 62(11):1684-8.
Score: 0.003